Genome-wide association study identifies common variants associated with circulating vitamin E levels

Human Molecular Genetics

Volumn 20, Issue 19, 2011, Pages 3876-3883

  Major, Jacqueline M ^a   Yu, Kai ^a   Wheeler, William ^b   Zhang, Hong ^a,c   Cornelis, Marilyn C ^d   Wright, Margaret E ^e   Yeager, Meredith ^a   Snyder, Kirk ^b   Weinstein, Stephanie J ^a   Mondul, Alison ^a   Eliassen, Heather ^f   Purdue, Mark ^a   Hazra, Aditi ^d   McCarty, Catherine A ^g   Hendrickson, Sara ^d   Virtamo, Jarmo ^h   Hunter, David ^d   Chanock, Stephen ^a   Kraft, Peter ^d   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c FUDAN UNIVERSITY   (China)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g MARSHFIELD CLINIC   (United States)

^h NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; GAMMA TOCOPHEROL; ZINC FINGER PROTEIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EUROPE; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL;

ADULT; AGED; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAMIN E;

EID: 80052708806     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr296     Document Type: Article

References (41)

1. Lonn, E., Bosch, J., Yusuf, S., Sheridan, P., Pogue, J., Arnold, J.M., Ross, C., Arnold, A., Sleight, P., Probstfield, J. et al. (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA, 293, 1338-1347.
2. Marchioli, R. (1999) Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol Res., 40, 227-238.
3. Marchioli, R., Schweiger, C., Levantesi, G., Tavazzi, L. and Valagussa, F. (2001) Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids, 36 (suppl.), S53-63.
4. Salonen, J.T., Nyyssonen, K., Tuomainen, T.P., Maenpaa, P.H., Korpela, H., Kaplan, G.A., Lynch, J., Helmrich, S.P. and Salonen, R. (1995) Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ, 311, 1124-1127.
5. Mayer-Davis, E.J., Costacou, T., King, I., Zaccaro, D.J. and Bell, R.A. (2002) Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care, 25, 2172-2177.
6. Lippman, S.M., Klein, E.A., Goodman, P.J., Lucia, M.S., Thompson, I.M., Ford, L.G., Parnes, H.L., Minasian, L.M., Gaziano, J.M., Hartline, J.A. et al. (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA, 301, 39-51.
7. Aggarwal, B.B., Sundaram, C., Prasad, S. and Kannappan, R. (2010) Tocotrienols, the vitamin E of the 21(st) century: it's potential against cancer and other chronic diseases. Biochem. Pharmacol, 80, 1613-1631.
8. Shklar, G. and Schwartz, J.L. (1996) Vitamin E inhibits experimental carcinogenesis and tumour angiogenesis. Eur. J. Cancer B. Oral Oncol., 32B, 114-119.
9. Sigounas, G., Anagnostou, A. and Steiner, M. (1997) dl-Alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr. Cancer, 28, 30-35.
10. Meydani, S.N. and Beharka, A.A. (1998) Recent developments in vitamin E and immune response. Nutr. Rev., 56, S49-58.
11. Hazra, A., Kraft, P., Selhub, J., Giovannucci, E.L., Thomas, G., Hoover, R.N., Chanock, S.J. and Hunter, D.J. (2008) Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat. Genet., 40, 1160-1162.
12. Ahn, J., Yu, K., Stolzenberg-Solomon, R., Simon, K.C., McCullough, M.L., Gallicchio, L., Jacobs, E.J., Ascherio, A., Helzlsouer, K., Jacobs, K.B. et al. (2010) Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet., 19, 2739-2745.
13. Ferrucci, L., Perry, J.R., Matteini, A., Perola, M., Tanaka, T., Silander, K., Rice, N., Melzer, D., Murray, A., Cluett, C. et al. (2009) Common variation in the beta-carotene 15,15′-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am. J. Hum. Genet., 84, 123-133.
14. Ouahchi, K., Arita, M., Kayden, H., Hentati, F., Ben Hamida, M., Sokol, R., Arai, H., Inoue, K., Mandel, J.L. and Koenig, M. (1995) Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat. Genet., 9, 141-145.
15. Sabatti, C., Service, S.K., Hartikainen, A.L., Pouta, A., Ripatti, S., Brodsky, J., Jones, C.G., Zaitlen, N.A., Varilo, T., Kaakinen, M. et al. (2009) Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat. Genet., 41, 35-46.
16. Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N.P., Rieder, M.J., Cooper, G.M., Roos, C., Voight, B.F., Havulinna, A.S. et al. (2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet., 40, 189-197.
17. Kooner, J.S., Chambers, J.C., Aguilar-Salinas, C.A., Hinds, D.A., Hyde, C.L., Warnes, G.R., Gomez Perez, F.J., Frazer, K.A., Elliott, P., Scott, J. et al. (2008) Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat. Genet., 40, 149-151.
18. Weissglas-Volkov, D., Aguilar-Salinas, C.A., Sinsheimer, J.S., Riba, L., Huertas-Vazquez, A., Ordonez-Sanchez, M.L., Rodriguez-Guillen, R., Cantor, R.M., Tusie-Luna, T. and Pajukanta, P. (2010) Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples. Circ. Cardiovasc. Genet., 3, 31-38.
19. Kathiresan, S., Willer, C.J., Peloso, G.M., Demissie, S., Musunuru, K., Schadt, E.E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T. et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet., 41, 56-65.
20. Willer, C.J., Sanna, S., Jackson, A.U., Scuteri, A., Bonnycastle, L.L., Clarke, R., Heath, S.C., Timpson, N.J., Najjar, S.S., Stringham, H.M. et al. (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet., 40, 161-169.
21. Teslovich, T.M., Musunuru, K., Smith, A.V., Edmondson, A.C., Stylianou, I.M., Koseki, M., Pirruccello, J.P., Ripatti, S., Chasman, D.I., Willer, C.J. et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466, 707-713.
22. Johansen, C.T., Kathiresan, S. and Hegele, R.A. (2011) Genetic determinants of plasma triglycerides. J. Lipid Res., 52, 189-206.
23. Hardwick, J.P. (2008) Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem. Pharmacol., 75, 2263-2275.
24. Sontag, T.J. and Parker, R.S. (2002) Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem., 277, 25290-25296.
25. Bardowell, S.A., Stec, D.E. and Parker, R.S. (2010) Common variants of cytochrome P450 4F2 exhibit altered vitamin E-{omega}-hydroxylase specific activity. J. Nutr., 140, 1901-1906.
26. McDonald, M.G., Rieder, M.J., Nakano, M., Hsia, C.K. and Rettie, A.E. (2009) CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol. Pharmacol., 75, 1337-1346.
27. Cha, P.C., Mushiroda, T., Takahashi, A., Kubo, M., Minami, S., Kamatani, N. and Nakamura, Y. (2010) Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese. Hum. Mol. Genet., 19, 4735-4744.
28. Borel, P., Moussa, M., Reboul, E., Lyan, B., Defoort, C., Vincent-Baudry, S., Maillot, M., Gastaldi, M., Darmon, M., Portugal, H. et al. (2007) Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J. Nutr., 137, 2653-2659.
29. Goti, D., Reicher, H., Malle, E., Kostner, G.M., Panzenboeck, U. and Sattler, W. (1998) High-density lipoprotein (HDL3)-associated alpha-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles. Biochem. J., 332, 57-65.
30. McCarthy, J.J., Somji, A., Weiss, L.A., Steffy, B., Vega, R., Barrett-Connor, E., Talavera, G. and Glynne, R. (2009) Polymorphisms of the scavenger receptor class B member 1 are associated with insulin resistance with evidence of gene by sex interaction. J. Clin. Endocrinol. Metab., 94, 1789-1796.
31. Acton, S., Osgood, D., Donoghue, M., Corella, D., Pocovi, M., Cenarro, A., Mozas, P., Keilty, J., Squazzo, S., Woolf, E.A. et al. (1999) Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb. Vasc. Biol., 19, 1734-1743.
32. Purdue, M.P., Johansson, M., Zelenika, D., Toro, J.R., Scelo, G., Moore, L.E., Prokhortchouk, E., Wu, X., Kiemeney, L.A., Gaborieau, V. et al. (2011) Nat. Genet., 43, 60-65.
33. Craig, W.Y., Palomaki, G.E. and Haddow, J.E. (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ, 298, 784-788.
34. Meenakshisundaram, R., Rajendiran, C. and Thirumalaikolundusubramanian, P. (2010) Lipid and lipoprotein profiles among middle aged male smokers: a study from southern India. Tob. Induc. Dis., 8, 11.
35. Venkatesan, A., Hemalatha, A., Bobby, Z., Selvaraj, N. and Sathiyapriya, V. (2006) Effect of smoking on lipid profile and lipid peroxidation in normal subjects. Indian J. Physiol. Pharmacol., 50, 273-278.
36. Kharb, S. and Singh, G.P. (2000) Clin. Chim. Acta, 302, 213-219.
37. The ATBC Cancer Prevention Study Group (1994) The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann. Epidemiol., 4, 1-10.
38. Milne, D.B. and Botnen, J. (1986) Retinol, alpha-tocopherol, lycopene, and alpha- and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin. Chem., 32, 874-876.
39. Kattermann, R., Jaworek, D., Moller, G., Assmann, G., Bjorkhem, I., Svensson, L., Borner, K., Boerma, G., Leijnse, B., Desager, J.P. et al. (1984) Multicentre study of a new enzymatic method of cholesterol determination. J. Clin. Chem. Clin. Biochem., 22, 245-251.
40. Hayes, R.B., Sigurdson, A., Moore, L., Peters, U., Huang, W.Y., Pinsky, P., Reding, D., Gelmann, E.P., Rothman, N., Pfeiffer, R.M. et al. (2005) Methods for etiologic and early marker investigations in the PLCO trial. Mutat. Res., 592, 147-154.
41. Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W. and Fu, P.C. (1974) Enzymatic determination of total serum cholesterol. Clin. Chem., 20, 470-475.